期刊文献+

益生菌对急性溃疡性结肠炎大鼠肠黏膜Toll样受体表达的影响 被引量:6

Effects of probiotics on the expression of TLRs in rat models of acute ulcerative colitis
原文传递
导出
摘要 目的探讨益生菌对溃疡性结肠炎(UC)大鼠模型肠黏膜Toll样受体(TLRs)表达的调控及其在UC发生发展中可能的作用机制。方法 40只SD大鼠随机分为正常对照组(A组)、模型组(B组)、金双歧治疗组(C组)、Toll样受体4单克隆抗体(TLR4m Ab)干预组(D组)。采用三硝基苯磺酸(TNBs)法造模,C组给予金双歧灌服,D组给予TLR4m Ab腹腔注射,第8天处死全部大鼠。对每组大鼠进行疾病活动指数(DAI)评分及组织病理学(HPS)评分,应用实时荧光定量(RT-PCR)法测定TLR4、TLR2 m RNA的表达。结果 B组DAI及HPS评分均明显高于A组(P<0.05),C组和D组较模型组均有所缓解(P<0.05)。TLR4、TLR2 m RNA在B组的表达明显高于A组,差异有统计学意义(P<0.05),而在C组和D组的表达差异无统计学意义(P>0.05)。结论 UC大鼠结肠组织中TLR4、TLR2表达异常,益生菌能抑制TLR4、TLR2的表达,可能是一种有效治疗UC的方法。 Objective To explore the effects of probiotics on the expression of TLRs in rat models of ulcerative colitis( UC) and its possible role in the pathogenesis of UC. Methods 40 SD rats were randomly divided into normal control group( group A), model group( group B), Jinshuangqi group( group C) and TLR4 m Ab group( group D). Group B,C and D were given trinitrobenzene sulfonic acid( TNBs) to induce acute intestinal inflammation,group C were given Jinshuangqi by oral gavage,and group D were given TLR4 m Ab intraperitoneal injection; all rats were sacrificed on the 8th day. To evaluate the disease activity index( DAI) score and colon histopathology score( HPS),the expression of TLR4,TLR2 m RNA were measured by real-time fluorescence quantitative( RT-PCR). Results The HPS and DAI scores in group B were significantly higher than in group A( P〈0. 05).Compared with the group B,group C and D were evidently lower( P〈0. 05). The expression of TLR4 and TLR2 m RNA in group B were evidently higher than in group A( P〈0. 05),while the differences between the group C and D were not observably significant( P〉0. 05). Conclusion The expression of TLR4 and TLR2 in the colonic tissue of UC rats is abnomal. Probiotics can inhibit the expression of TLR4 and TLR2,and may be an effective method for the treatment of UC.
出处 《中国微生态学杂志》 CAS CSCD 2015年第7期749-752,共4页 Chinese Journal of Microecology
基金 新疆维吾尔自治区自然科学基金(2013211A092)
关键词 溃疡性结肠炎 肠道菌群 TOLL样受体 益生菌 Ulcerative colitis Intestinal flora Toll-like receptor Probiotics
  • 相关文献

参考文献6

二级参考文献49

  • 1Hai-Mei Zhao,Xiao-Ying Huang,Zhi-Qin Zuo,Qi-Hong Pan,Mei-Ying Ao,Feng Zhou,Hong-Ning Liu,Zhi-Yong Liu,Duan-Yong Liu.Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice[J].World Journal of Gastroenterology,2013,19(5):742-749. 被引量:15
  • 2梁泉,薛承锐.Toll样受体4的研究进展[J].天津医科大学学报,2006,12(1):150-153. 被引量:9
  • 3华荣,荣新洲.Toll样受体4研究进展[J].中华烧伤杂志,2006,22(2):150-153. 被引量:4
  • 4Benoit Foligne,Sophie Nutten,Corinne Grangette,Véronique Dennin,Denise Goudercourt,Sabine Poiret,Joelle Dewulf,Dominique Brassart,Annick Mercenier,Bruno Pot.Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria[J].World Journal of Gastroenterology,2007,13(2):236-243. 被引量:22
  • 5Bernstein CN,Fried M,Hamid S,et al.Inflammatory bowel disease:a global perspective.World Gastroenterology Organisation Practice Guideline.Inflamm Bowel Dis,2010,16:112-124.
  • 6Panaccione R,Rutgeerts P,Sandborn WJ,et al.Review article:treatment algorithms to maximize remission and minimize orticosteroid dependence in patients with inflammatory bowel disease.Aliment Pharmacol Ther,2008,28:674-688.
  • 7Bernstein CN,Shanahan F.Disorders of a modern lifestyle:reconciling the epidemiology of inflammatory bowel disease.Gut,2008,57:1185-1191.
  • 8Duerr RH,Taylor KD,Brant SR,et al.A genome-wide association stydy identifies IL23 R as an inflammatory bowel disease gene.Science,2006,314:1461-1463.
  • 9Hampe J,Franke A,Rosenstiel P,et al.A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.Nat Genet,2007,39:207-211.
  • 10Darfeuille-Michaud A,Boudeau J,Bulois P,et al.High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.Gastroenterology,2004,127:412-421.

共引文献76

同被引文献78

  • 1Siqqers RH,Hzckam DJ.The role of innate immune-stimulated epithelia apoptosis during gastrointestinal inflammatory diseases[J].Cell Mol Life Sci,2011;68(22):3623-34.
  • 2Pedersen G.Development,validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium[J].Dan Med J,2015;62(1):B4973.
  • 3Bantel H,Berg C,Vieth M,et al.Mesalazine inhibits activation of transcription factor NF-κB in inflamed mucosa of patients with ulcerative colitis[J].Am J Gastroenterol,2000;95(12):3452-7.
  • 4Mann ER,Bernardo D,Ng SC,et al.Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis,characterized by increased IL-4 production and loss of IL-22 and IFN[J].Inflamm Bowel Dis,2014;20(12):2299-307.
  • 5Ljotsson B,Andersson G,Andersson E,et al. Acceptabili-ty ,effectiv-eness, and cost-effectiveness of internet-basedexposure treatment for irritable bowel syndrome in a clini-cal sample : a randomized controlled trial [J]. BMC Gas-troenterol ,2011,11 (1): 110.
  • 6Simr6n Ml,Barbara G,Flint HJ,et al. Intestinal micro-biota in functi- onal bowel disorders : a Rome foundationreport [J], Gut,2013,62( 1) : 159-176.
  • 7Parkes GC, Rayment NB, Hudspith BN,et al. Distinctmicrobial pop- ulations exist in the mucosn-nssociatedof sub-groups of irritable bowel syndrome [J]. Neurogas-troenterol Motil, 2012,24( 1): 31-39.
  • 8Kahouli I, Tomaro -Duchesneau C, Prakash S. Probioticsin colorectal cancer (CRC) with emphasis on mecha-nisms of action and current perspectives [J]. J Med Mi-crobiol, 2013, 62(Pt8):1107-1123.
  • 9Jadad AR,Moore RA, Carroll D,et al. Assessing thequality of reports of randomized clinical trials : Is blind-ing necessary [J]. Control Clinic Trials,2012,17(1) : 126-128.
  • 10Kassinen A,Krogius -Kurikka L,Makivuokko H ,et al.The fecal microbiota of irritable bowel syndrome patientsdiffers significantly from that of healthy subjects [J].Gastroent- erology,2007,133(1) :24-33.

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部